The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 120.00
Bid: 119.00
Ask: 120.00
Change: -3.00 (-2.44%)
Spread: 1.00 (0.84%)
Open: 123.50
High: 123.50
Low: 118.00
Prev. Close: 123.00
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

14 Jan 2021 07:00

RNS Number : 6091L
Bakkavor Group PLC
14 January 2021
 

14 January 2021

 

Bakkavor Group plc

Trading update 

A strong and resilient performance in unprecedented conditions 

Bakkavor, the international provider of fresh prepared food (FPF), provides an update on trading for the 52 weeks ended 26 December 2020, ahead of its full-year results announcement on 16 March 2021.

At a Group level, the encouraging recovery in sales reported at the end of H1 continued into the second half, with Group revenue for the full year 4.9% lower than the prior year and 4.9% lower on a like-for-like basis.

In the UK, we were reassured by a recovery in sales as the first COVID-19 lockdown was lifted, however, volumes were adversely impacted in the final quarter by further restrictions, particularly within the 'Food to go' category. Forward planning and preparation for the all-important Christmas period enabled us to maintain very high customer service levels and deliver Christmas volumes in line with the prior year. Overall, UK like-for-like sales for the full year were 5.3% lower than last year.

Looking at our International segment, the US business grew by 12.7% on a like-for-like basis as we benefited from the growing trend for FPF and greater collaboration with our customers.  This revenue uplift, together with a strategic restructuring of our operations, has led to a turnaround in performance and secured sustainable and profitable growth for the second half of the year.

The growth reported within the US was, however, offset by a decline in revenues of 21.6% in China; our business most severely impacted by the pandemic. Whilst we continued to see reduced demand in Hong Kong due to ongoing civil unrest, we saw a steady improvement in sales in mainland China in the second half of the year, giving us confidence in the overall recovery in the region. 

Decisive mitigating actions were taken to lower our cost base and preserve cash at an early stage of the pandemic. We rapidly adapted factory operations and completed strategic restructurings in all regions to accommodate lower volumes. As a result, when combined with improved trading in H2, the Group believes it will deliver adjusted EBITDA (pre IFRS 16) for the full year broadly in line with the £138m reported in the prior year.  Furthermore, we maintained our focus on cash management, which included a temporary reduction in non-essential capital expenditure and a suspension of dividend payments. We therefore continue to operate with significant headroom of £200m against our debt facilities of £537.5m.

Thorough planning ensured we were well-prepared ahead of the UK's exit from the European Union on 31 December 2020. We worked closely with suppliers and customers to put in place processes to mitigate any adverse risk to supply, and we continue to support colleagues in obtaining UK settled status. Although it is early days, these measures have minimised disruption to our business and our supply chain continues to operate effectively.

 

Agust Gudmundsson, Chief Executive Officer, said:

"These are unprecedented times but the hard work and dedication of our teams, together with our scale and long-standing customer relationships, has delivered a strong and resilient performance. I am incredibly proud of our colleagues who have gone above and beyond in the toughest of circumstances. Their performance has been exceptional and I would like to thank them once again.

"Notwithstanding the ongoing impact of COVID-19, we have a sound business model and solid platform that leaves us well placed to navigate the current environment and achieve long-term sustainable growth."

 

ENQUIRIES

Institutional investors and analysts:

 

Ben Waldron, Chief Financial Officer

 

Sally Barrett-Jolley, Head of Corporate Affairs

+44 (0) 20 7908 6143

Media

 

Tulchan Communications

+44 (0) 20 7353 4200

Will Smith, Will Palfreyman

 

 

 

 

 

ABOUT BAKKAVOR 

Bakkavor is the leading provider of fresh prepared food ("FPF") in the UK, with a growing international presence in the US and China. The Group is the number one by market share in the UK in the four FPF product categories of meals, salads, desserts and pizza & bread, providing high-quality, fresh, healthy and convenient food. Its customers include some of the UK's leading grocery retailers, including Tesco, Marks & Spencer, Sainsbury's and Waitrose. The Group's International segment operates in the US and China. Bakkavor was founded in 1986 and has its headquarters in London. The Group has over 20,000 employees and operates 23 factories in the UK, 5 in the US and 9 in China. 

 

DISCLAIMER - FORWARD-LOOKING STATEMENTS 

This statement, prepared by Bakkavor Group plc (the "Company"), may contain forward-looking statements about Bakkavor Group plc and its subsidiaries (the "Group"). Forward-looking statements involve uncertainties because they relate to events, and depend on circumstances, that will, or may, occur in the future. If the assumptions on which the Group bases its forward-looking statements change, actual results may differ from those expressed in such statements. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update these forward-looking statements. Nothing in this statement should be construed as a profit forecast. Some numbers and period on period percentages in this statement have been rounded or adjusted in order to ensure consistency with the financial information. 

 

LEI number: 213800COL7AD54YU9949 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQXLFFFFLEBBZ
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.